Linked Life Data

16945618

Source:http://linkedlifedata.com/resource/pubmed/id/16945618

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-9-1
pubmed:abstractText
The acute porphyrias are rare inherited diseases characterized by acute episodes of life-threatening symptoms. Hemin was approved for treating these disorders in 1983. This open-label study of hemin therapy, conducted to demonstrate the safety of hemin manufactured in a new facility, is the largest to date and provides an overview of the use of hemin in clinical practice in the United States.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1555-7162
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
119
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
801.e19-24
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Open-label study of hemin for acute porphyria: clinical practice implications.
pubmed:affiliation
Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston 77555-1109, USA. kanderso@utmb.edu
pubmed:publicationType
Journal Article